Hyderabad's Hetero Group enters UAE with new venture

The first phase of the collaboration will be distribution of Hetero's medicines in the UAE, Chairman of Hetero Group B P S Reddy said.

The group markets its products in 138 nations. Reddy said in the first phase starting in January, Nexgen Pharma will distribute 21 products, more than doubling this to 50 products upon the completion of the registration process in the next two years.

"By 2016, Nexgen Pharma will be distributing 100 products," Reddy said.

Both pharmaceutical firms announced a joint venture agreement to form a distribution firm in the first phase of their partnership. The new entity will distribute Hyderabad-based Hetero's pharmaceuticals in the UAE.

The drugs to be distributed next year will include branded generics in various therapeutic segments such as gastroenterology, cardiovascular, neurology, antivirals, antiretrovirals and antihistamines.

  

image
Business Standard
177 22
Business Standard

Hyderabad's Hetero Group enters UAE with new venture

Press Trust of India  |  Dubai 

The first phase of the collaboration will be distribution of Hetero's medicines in the UAE, Chairman of Hetero Group B P S Reddy said.

The group markets its products in 138 nations. Reddy said in the first phase starting in January, Nexgen Pharma will distribute 21 products, more than doubling this to 50 products upon the completion of the registration process in the next two years.

"By 2016, Nexgen Pharma will be distributing 100 products," Reddy said.

Both pharmaceutical firms announced a joint venture agreement to form a distribution firm in the first phase of their partnership. The new entity will distribute Hyderabad-based Hetero's pharmaceuticals in the UAE.

The drugs to be distributed next year will include branded generics in various therapeutic segments such as gastroenterology, cardiovascular, neurology, antivirals, antiretrovirals and antihistamines.

  

RECOMMENDED FOR YOU

Hyderabad's Hetero Group enters UAE with new venture

Abu Dhabi-based Neopharma has set up a joint venture with Hyderabad-based Hetero Group -- Nexgen Pharma -- to manufacture medicines in the UAE, the company said in a statement.

The first phase of the collaboration will be distribution of Hetero's medicines in the UAE, Chairman of Hetero Group B P S Reddy said.

The group markets its products in 138 nations. Reddy said in the first phase starting in January, Nexgen Pharma will distribute 21 products, more than doubling this to 50 products upon the completion of the registration process in the next two years.

"By 2016, Nexgen Pharma will be distributing 100 products," Reddy said.

Both pharmaceutical firms announced a joint venture agreement to form a distribution firm in the first phase of their partnership. The new entity will distribute Hyderabad-based Hetero's pharmaceuticals in the UAE.

The drugs to be distributed next year will include branded generics in various therapeutic segments such as gastroenterology, cardiovascular, neurology, antivirals, antiretrovirals and antihistamines.

  
image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard